Effect of treatment with paromomycin on endotoxemia in <font color="blue">patients_2</font> <font color="blue">with_2</font> <font color="blue">alcoholic_3</font> <font color="blue">liver_3</font> <font color="blue">disease_3</font> <font color="blue">--_3</font> a double - blind , placebo - controlled trial . 
<br>
<br> The results of experimental and clinical studies support the hypothesis that gut - derived endotoxins might be of relevance for the development and course of <font color="blue">alcoholic_1</font> <font color="blue">liver_1</font> <font color="blue">disease_1</font> <font color="blue">._1</font> The aim of this study was to test the effect of a nonabsorbable , broad - spectrum antibiotic on endotoxemia in <font color="blue">patients_3</font> <font color="blue">with_3</font> <font color="blue">alcoholic_4</font> <font color="blue">liver_4</font> <font color="blue">disease_4</font> <font color="blue">._4</font> <font color="blue">Fifty_5</font> <font color="blue">patients_5</font> <font color="blue">with_5</font> <font color="blue">alcoholic_5</font> <font color="blue">liver_5</font> <font color="blue">disease_5</font> <font color="blue">(_4</font> <font color="blue">27_4</font> <font color="blue">with_4</font> <font color="blue">cirrhosis_4</font> <font color="blue">,_4</font> <font color="blue">23_4</font> <font color="blue">without_4</font> <font color="blue">cirrhosis_4</font> <font color="blue">)_4</font> were randomly assigned to receive either paromomycin sulfate ( 3 x 1 g / day ) or placebo in a double - blind fashion for at least 3 weeks , and if possible 4 weeks . Endotoxin concentration , liver function tests , and other laboratory parameters were determined in weekly intervals . Endotoxin concentration was also determined in <font color="blue">15_1</font> <font color="blue">healthy_1</font> <font color="blue">controls_1</font> <font color="blue">._1</font> Groups receiving paromomycin or placebo were similar for clinical and biological items collected initially . Mean initial endotoxin concentrations were significantly elevated in both groups ( mean + /- SEM ; paromomycin , 16.7 + /- 5.3 pg / ml ; placebo , 17.5 + /- 6.9 pg / ml ; healthy controls , 2.3 + /- 0.4 pg / ml ) . Although the mean endotoxin concentration was lower in <font color="blue">the_1</font> <font color="blue">verum_1</font> <font color="blue">group_1</font> after 1 week ( paromomycin , 8.0 + /- 1.9 pg / ml ; placebo , 14.6 + /- 3.5 pg / ml ; p > 0.05 ) , paromomycin treatment had no significant effect on endotoxin concentration or liver function tests during the 4-week period . The beneficial effect of paromomycin treatment on endotoxemia in cirrhotics reported in earlier studies could not be reproduced under the conditions of this trial in <font color="blue">patients_2</font> <font color="blue">with_2</font> <font color="blue">alcoholic_3</font> <font color="blue">liver_3</font> <font color="blue">disease_3</font> <font color="blue">._3</font>